Literature DB >> 2156825

Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries.

R A Heller1, K Song, D Villaret, R Margolskee, J Dunne, H Hayakawa, G M Ringold.   

Abstract

As an approach to isolate the cell-surface receptor for tumor necrosis factor (TNF), we have developed transfectants of human B-lymphoblastoid cells (UC cells) that overexpress the TNF receptor. These transfectants were isolated from UC cells transfected with cDNA libraries of HeLa or NG108 cells constructed in the mammalian expression vector EBO-pcD. This vector contains the Epstein-Barr virus origin of replication (ori-P) plus the EBNA-1 gene conferring replication function to ori-P and, therefore, the ability to replicate autonomously within the transfected cell (Margolskee, R.F., Kavathas, P., and Berg, P. (1988) Mol. Cell. Biol. 8, 2837-2947). Cells overexpressing the TNF receptor were identified and separated by the binding of fluoresceinated TNF and flow cytometric selection. Scatchard analysis of 125I-TNF binding data revealed a single class of high affinity receptors with a dissociation constant (Kd) of 0.2 to 2 nM and a receptor density of about 150,000 per cell, an increase of approximately 150-fold over UC cells. Cross-linking of receptor-ligand with bis-sulfosuccinimidyl suberate followed by polyacrylamide gel electrophoresis gave estimates of 87 and 104 kDa for the size of the complex. Based on its ability to bind TNF, a 68-kDa receptor protein was identified in cell extracts enriched for the receptor by using immobilized wheat germ agglutinin and TNF affinity chromatography. The difference in the estimated size of the receptor and the receptor-ligand complexes demonstrates that TNF binds to the receptor as a monomer or a dimer. Analysis of cDNA sequences conferring receptor amplification in transfectants revealed that plasmid DNA was present at 30 or more copies per cell, most likely integrated into the genomic DNA or organized into high molecular weight catenanes, and autonomously replicating units could not be recovered. Therefore, while this vector was useful in generating stable receptor-amplified cells, it was not maintained as a recoverable episome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156825

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

Authors:  R A Heller; K Song; M A Onasch; W H Fischer; D Chang; G M Ringold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells.

Authors:  A De Benedetti; R E Rhoads
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

3.  Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT-) using an Epstein-Barr virus-derived cDNA expression vector.

Authors:  P B Belt; W Jongmans; J de Wit; J H Hoeijmakers; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

4.  Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.

Authors:  Y Wang; S M Camp; M Niwano; X Shen; J C Bakowska; X O Breakefield; P D Allen
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 5.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

6.  Studies on phenotypic complementation of ataxia-telangiectasia cells by chromosome transfer.

Authors:  W Jongmans; G W Verhaegh; N G Jaspers; M Oshimura; E J Stanbridge; P H Lohman; M Z Zdzienicka
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

7.  Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine.

Authors:  C Philippe; P Roux-Lombard; B Fouqueray; J Perez; J M Dayer; L Baud
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.